Migrepam coated tablets 2,5mg х2 №1

Use Migrepam is intended for the relief of migraine attacks with and without aura. The effect of zolmitriptan on headache and other migraine symptoms (such as nausea, photophobia, phonophobia) was noted within 1 hour and increased within 2 to 4 hours after taking the drug. Zolmitriptan is equally effective for migraine with aura, migraine without aura, and menstruation-associated migraine. Taking zolmitriptan during an aura does not prevent migrainous headache, so the drug should be taken after the onset of the pain attack. How to take The recommended dose for relieving a migraine attack is 2.5 mg (1 tablet). It is recommended to take the drug as early as possible from the onset of headache, but it is also effective when taken later in the attack. If the therapeutic effect was not achieved after taking a 2.5 mg dose, Migrepam in a 5 mg dose (2 tablets) can be used to relieve subsequent migraine attacks. No more than 2 doses of Migrepam should be taken per day. The total daily dose of zolmitriptan should not exceed 10 mg (4 tablets). Migrepam is not indicated for migraine prophylaxis. Contraindications Migrepam can only be used in cases of clearly diagnosed migraine. Before prescribing zolmitriptan, other possible serious neurological diseases should be ruled out in patients with previously undiagnosed migraine, as well as in patients with a confirmed diagnosis of migraine who have atypical symptoms. Zolmitriptan is not indicated for the treatment of hemiplegic, basilar, and ophthalmoplegic migraine. Zolmitriptan should not be used in patients with Wolff-Parkinson-White syndrome or arrhythmias associated with other accessory conduction pathways. In patients taking serotonin 5-HT1B/1D receptor agonists, cerebrovascular disorders, including strokes, have been observed. Storage Storage temperature: from +2degreeC to +25degreeC․